Evidence map›Paper›PMID 19238561›Full record

ArticlePlant molecular biology2009

The maize ZmMYB42 represses the phenylpropanoid pathway and affects the cell wall structure, composition and degradability in Arabidopsis thaliana.

Fathi-Mohamed Sonbol, Silvia Fornalé, Montserrat Capellades, Antonio Encina, Sonia Touriño, Josep-Lluís Torres, Pere Rovira, Katia Ruel, Pere Puigdomènech, Joan Rigau and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Plant molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. International journal of molecular sciences · 2024
    Article
  7. Review
  8. Review
  9. Cloning ofInternational journal of molecular sciences · 2023
    Article
  10. Article
  11. Ectopic Expression ofInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Genetic Determinants of Biomass in CFrontiers in plant science · 2022
    Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fathi-Mohamed SonbolConsorci CSIC-IRTA-UAB, Centre de Recerca en AgriGenomica (CRAG), Barcelona, Spain.
Silvia Fornalé
Montserrat Capellades
Antonio Encina
Sonia Touriño
Josep-Lluís Torres
Pere Rovira
Katia Ruel
Pere Puigdomènech
Joan Rigau
David Caparrós-Ruiz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The involvement of the maize ZmMYB42 R2R3-MYB factor in the phenylpropanoid pathway and cell wall structure and composition was investigated by overexpression in Arabidopsis thaliana. ZmMYB42 down-regulates several genes of the lignin pathway and this effect reduces the lignin content in all lignified tissues. In addition, ZmMYB42 plants generate a lignin polymer with a decreased S to G ratio through the enrichment in H and G subunits and depletion in S subunits. This transcription factor also regulates other genes involved in the synthesis of sinapate esters and flavonoids. Furthermore, ZmMYB42 affects the cell wall structure and degradability, and its polysaccharide composition. Together, these results suggest that ZmMYB42 may be part of the regulatory network controlling the phenylpropanoid biosynthetic pathway.

Indexed as

ArabidopsisCell WallEstersFlavonoidsGene Expression Regulation, PlantLigninMalatesPhenylpropionatesPlant ProteinsPlants, Genetically ModifiedTranscription FactorsZea mays2-O-sinapoylmalateEstersFlavonoidsLigninMalatesPhenylpropionatesPlant ProteinsTranscription Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.